105 results
Page 4 of 6
8-K
EX-99.1
rkkmhvvrv6
9 Aug 21
Pulse Biosciences Reports Second Quarter 2021 Financial Results
4:32pm
8-K
EX-99.1
bcdba
1 Jul 21
Pulse Biosciences Announces $50 Million Private Placement
8:33am
8-K
EX-99.1
2i5dp3f
9 Jun 21
Pulse Biosciences Announces Health Canada Approval for CellFX® System
8:22am
SD
EX-1.01
xq51 92j4h361
28 May 21
Conflict minerals disclosure
4:41pm
8-K
EX-99.1
0v5bie9b v1h8cifx55
10 May 21
Pulse Biosciences Reports First Quarter 2021 Financial Results
4:23pm
8-K
EX-99.1
33xehkj1i5
22 Feb 21
Pulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
4:18pm
424B5
tz1e9a6uzzewc f8
4 Feb 21
Prospectus supplement for primary offering
8:46am
8-K
EX-99.1
oeknsdub4n9x24i
4 Feb 21
Pulse Biosciences, Inc. Announces At-The-Market Equity Offering Program
8:30am
8-K
EX-99.1
3obai
3 Feb 21
Pulse Biosciences Announces FDA Clearance for the CellFX® System
4:13pm
8-K
EX-99.1
h2i7t5
25 Jan 21
Pulse Biosciences Announces CE Mark Approval for CellFX® System
8:12am
8-K
EX-99.1
nlm ackbp
5 Jan 21
Pulse Biosciences, Inc. Announces Redemption of Warrants
9:16am
8-K
EX-99.1
qre8 b3bq6
9 Nov 20
Pulse Biosciences Reports Third Quarter 2020 Financial Results
4:29pm
8-K
EX-99.1
kosehovldxzq0ov czb0
10 Aug 20
Pulse Biosciences Reports Second Quarter 2020 Financial Results
4:27pm
8-K
EX-99.1
em4z pps8pcrr2p
6 Aug 20
Pulse Biosciences, Inc. Appoints Richard van den Broek to Board of Directors
5:00pm